Growth Metrics

Solid Biosciences (SLDB) Assets Average (2018 - 2026)

Quarterly results put Assets Average at $327.7 million for Q1 2026, up 23.07% from a year ago — trailing twelve months through Mar 2026 was $327.7 million (up 23.07% YoY), and the annual figure for FY2025 was $210.6 million, up 19.12%.

Solid Biosciences has reported Assets Average over the past 9 years, most recently at $327.7 million for Q1 2026.

  • Assets Average reached $327.7 million in Q1 2026 per SLDB's latest filing, up from $253.2 million in the prior quarter.
  • Across five years, Assets Average topped out at $327.7 million in Q1 2026 and bottomed at $174.8 million in Q4 2023.
  • Median Assets Average over the past 5 years was $221.4 million (2024), compared with a mean of $236.0 million.
  • The largest annual shift saw Assets Average dropped 24.51% in 2022 before it skyrocketed 35.97% in 2025.
  • Over 5 years, Assets Average stood at $222.4 million in 2022, then fell by 21.37% to $174.8 million in 2023, then rose by 14.53% to $200.2 million in 2024, then grew by 26.46% to $253.2 million in 2025, then increased by 29.42% to $327.7 million in 2026.
  • Business Quant data shows Assets Average for SLDB at $327.7 million in Q1 2026, $253.2 million in Q4 2025, and $291.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 13.04 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 33.42 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 1.72 Bn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 331.70 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 40.89 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 26.06 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 40.71 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - 26.03 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 5.05 Bn
10 Solid Biosciences 713.77 Mn 333.09 Mn - 327.72 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 327.72 Mn
Dec 31, 2025 253.23 Mn
Sep 30, 2025 291.10 Mn
Jun 30, 2025 326.10 Mn
Mar 31, 2025 266.28 Mn
Dec 31, 2024 200.24 Mn
Sep 30, 2024 221.40 Mn
Jun 30, 2024 239.84 Mn
Mar 31, 2024 206.81 Mn
Dec 31, 2023 174.83 Mn
Sep 30, 2023 194.72 Mn
Jun 30, 2023 217.15 Mn
Mar 31, 2023 244.92 Mn
Dec 31, 2022 222.36 Mn
Sep 30, 2022 196.49 Mn
Jun 30, 2022 208.03 Mn
Mar 31, 2022 219.97 Mn
Dec 31, 2021 240.68 Mn
Sep 30, 2021 257.42 Mn
Jun 30, 2021 275.57 Mn
Mar 31, 2021 228.22 Mn
Dec 31, 2020 105.84 Mn
Sep 30, 2020 49.24 Mn
Jun 30, 2020 65.96 Mn
Mar 31, 2020 88.72 Mn
Dec 31, 2019 117.20 Mn
Sep 30, 2019 113.62 Mn
Jun 30, 2019 108.27 Mn
Mar 31, 2019 129.92 Mn
Dec 31, 2018 148.20 Mn
Sep 30, 2018 164.14 Mn
Jun 30, 2018 180.36 Mn
Mar 31, 2018 132.72 Mn